콘텐츠로 건너뛰기
Merck
  • DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activities.

DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activities.

Molecular cell (2013-12-10)
Atsushi Shibata, Davide Moiani, Andrew S Arvai, Jefferson Perry, Shane M Harding, Marie-Michelle Genois, Ranjan Maity, Sari van Rossum-Fikkert, Aryandi Kertokalio, Filippo Romoli, Amani Ismail, Ermal Ismalaj, Elena Petricci, Matthew J Neale, Robert G Bristow, Jean-Yves Masson, Claire Wyman, Penny A Jeggo, John A Tainer
초록

MRE11 within the MRE11-RAD50-NBS1 (MRN) complex acts in DNA double-strand break repair (DSBR), detection, and signaling; yet, how its endo- and exonuclease activities regulate DSBR by nonhomologous end-joining (NHEJ) versus homologous recombination (HR) remains enigmatic. Here, we employed structure-based design with a focused chemical library to discover specific MRE11 endo- or exonuclease inhibitors. With these inhibitors, we examined repair pathway choice at DSBs generated in G2 following radiation exposure. While nuclease inhibition impairs radiation-induced replication protein A (RPA) chromatin binding, suggesting diminished resection, the inhibitors surprisingly direct different repair outcomes. Endonuclease inhibition promotes NHEJ in lieu of HR, while exonuclease inhibition confers a repair defect. Collectively, the results describe nuclease-specific MRE11 inhibitors, define distinct nuclease roles in DSB repair, and support a mechanism whereby MRE11 endonuclease initiates resection, thereby licensing HR followed by MRE11 exonuclease and EXO1/BLM bidirectional resection toward and away from the DNA end, which commits to HR.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Mirin, ≥98% (HPLC), powder
Sigma-Aldrich
PFM39, ≥98% (HPLC)
Sigma-Aldrich
GeneJuice® Transfection Reagent, Non-lipid based chemical transfection reagent optimized for maximum transfection efficiency, ease-of-use, and minimal cytotoxicity on a wide variety of mammalian cells.